Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Michael Tarantino, James B. Bussel, MD, Victor S. Blanchette, MD, Donald Beam, John Roy, Jenny M. Despotovic, DO, MS, Ashok Raj, Nancy Carpenter, Bhakti Mehta, Melissa Eisen

Blood (2017) 130 (Supplement 1): 14.

https://doi.org/10.1182/blood.V130.Suppl_1.14.14

Published: 2017

Journal Articles

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John D. Grainger, MD MRCP, FRPATH, James B. Bussel, MD, Michael Tarantino, Nicola Cooper, MA, MD MRCP, FRCPath, Donald Beam, Jenny M. Despotovic, DO, MS, Alexey Maschan, MD PhD Professor, Nancy Carpenter, Melissa Eisen, Joseph Park

Blood (2017) 130 (Supplement 1): 2334.

https://doi.org/10.1182/blood.V130.Suppl_1.2334.2334

Published: 2017

Journal Articles

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

John Grainger, James B. Bussel, MD, Nichola Cooper, Michael Tarantino, Victor Blanchette, Jenny Despotovic, Alexey Maschan, MD PhD, Nancy Carpenter, Melissa Eisen, Bhakti Mehta

Blood (2016) 128 (22): 869.

https://doi.org/10.1182/blood.V128.22.869.869

Published: 2016

Journal Articles

Unmet Needs in Diagnosis and Treatment of Glanzmann’s Thrombasthenia (GT): Perceptions of US Hematologists and Nurses

Meera B. Chitlur, MD, Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Ellis J. Neufeld, MD PhD, Craig M. Kessler, MD, Mark Reding, Michael Tarantino, MD, David L. Cooper, MD MBA

Blood (2014) 124 (21): 2179.

https://doi.org/10.1182/blood.V124.21.2179.2179

Published: 2014

Journal Articles

International consensus report on the investigation and management of primary immune thrombocytopenia

Blood (2010) 115 (2): 168–186.

https://doi.org/10.1182/blood-2009-06-225565

Published: 2010

Includes: Supplemental data

Journal Articles

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Gregory Cheng, Michael Tarantino, MD, Terry Gernsheimer, MD, Oliver Meyer, Andres Brainsky, Nicole L. Stone

Blood (2009) 114 (22): 3517.

https://doi.org/10.1182/blood.V114.22.3517.3517

Published: 2009

Journal Articles

Winrho: Safety and Efficacy during Pregnancy

Caroline Cromwell, MD, Michael Tarantino, MD, Louis M. Aledort, MD

Blood (2008) 112 (11): 4543.

https://doi.org/10.1182/blood.V112.11.4543.4543

Published: 2008

Journal Articles

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

Connie H. Miller, PhD, Craig Hooper, PhD, Thomas C. Abshire, MD, Paula L. Bockenstedt, MD, Doreen B. Brettler, MD, Jorge Di Paola, MD, Gita Massey, MD, Anne T. Neff, MD, Amy D. Shapiro, MD, Michael Tarantino, MD, Brian M. Wicklund, MD, MPH, Marilyn J. Manco-Johnson, MD, Amy L. Dunn, MD, Christine Knoll, MD, Melissa Creary, MPH, Jane Benson, Dorothy Ellingsen, Jennifer Driggers, J. Michael Soucie, PhD

Blood (2008) 112 (11): 1017.

https://doi.org/10.1182/blood.V112.11.1017.1017

Published: 2008

Journal Articles

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

Michael Tarantino, MD, Usha Sunkara, MD, James George, MD, Louis M. Aledort, MD, Matthew Guo, PhD, Dietmar Berger, MD, PhD, Terry Gernsheimer, MD

Blood (2008) 112 (11): 3422.

https://doi.org/10.1182/blood.V112.11.3422.3422

Published: 2008

Journal Articles

Experience with a Modified Nijmegen-Bethesda Method for Measurement of Inhibitors in Hemophilia Patients: The CDC Inhibitor Surveillance Pilot Project.

Connie H. Miller, PhD, S. Jean Platt, MT-ASCP, Thomas Abshire, M.D., Doreen Brettler, M.D., Paula Brockenstedt, M.D., Jorge DiPaola, M.D., Gita Massey, M.D., Anne Neff, M.D., Amy Shapiro, M.D., Michael Tarantino, M.D., Brian Wicklund, M.D., Melissa Creary, MA, J. Michael Soucie, Ph.D.

Blood (2007) 110 (11): 1156.

https://doi.org/10.1182/blood.V110.11.1156.1156

Published: 2007

NARROW

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Unmet Needs in Diagnosis and Treatment of Glanzmann’s Thrombasthenia (GT): Perceptions of US Hematologists and Nurses

International consensus report on the investigation and management of primary immune thrombocytopenia

Platelet Counts Following Eltrombopag Discontinuation in Patients with Chronic Immune Thrombocytopenic Purpura.

Winrho: Safety and Efficacy during Pregnancy

Factor VIII and Factor IX Mutation Analysis in 600 U.S. Hemophilia Patients: Correlation of Mutation Type with History of Inhibitor

Evaluation of Bleeding and Thrombotic Events during Long-Term Use of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura.

Experience with a Modified Nijmegen-Bethesda Method for Measurement of Inhibitors in Hemophilia Patients: The CDC Inhibitor Surveillance Pilot Project.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only